Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134: S390-S393
DOI: 10.1055/s-0029-1243048
DOI: 10.1055/s-0029-1243048
Übersicht | Review article
Pneumologie© Georg Thieme Verlag KG Stuttgart · New York
Bedeutung der Feinpartikeldosis und der kleinen Atemwege für die Therapie des Asthma bronchiale mit Fixkombinationen
Role of particulate matter and small airways in treatment of asthma with inhalative fixcombinationsFurther Information
Publication History
eingereicht: 16.2.2009
akzeptiert: 14.5.2009
Publication Date:
25 November 2009 (online)

Schlüsselwörter
Asthmatherapie - periphere Atemwege - intrapulmonale Deposition - Trockenpulverinhalator - Treibgasdosieraerosole
Keywords
asthma therapy - small airways - lung deposition - dry powder inhaler - metered dose inhaler
Literatur
- 1
Borgström L, Olsson B, Thorsson L.
Degree of throat deposition can explain the
variability in lung deposition of inhaled drugs.
Aerosol
Med.
2006;
19
473-483
MissingFormLabel
- 2
Busse W W, Banks-Schlegel S, Wenzel S E.
Pathophysiology of severe asthma.
J
Allergy Clin Immunol.
2000;
106
1033-1042
,
MissingFormLabel
- 3
Carroll N, Cooke C, James A.
The distribution of eosinophils and lymphocytes in the large
and small airways of asthmatics.
Eur Respir J.
1997;
10
292-300
MissingFormLabel
- 4
Cohen J, Douma W R, ten Hacken N HT, Vonk J M, Oudkerk M, Postma D S.
Ciclesonide
improves measures of small airway involvement in asthma.
Eur
Respir J.
2008;
31
1213-1220
MissingFormLabel
- 5
Downie S R, Salome C M, Verbanck S, Thompson B, Berend N, King G G.
Ventilation heterogeneity
is a major determinant of airway hyperresponsiveness in asthma,
independent of airway inflammation.
Thorax.
2007;
62
684-689
MissingFormLabel
- 6
Haidl P, Schmidt F, Wiese C, Koehler D.
Peak inspiratory flow
rate after methacholine challenge in asthmatic patients and its
impact on the effect of formoterol via different inhalers.
J
Aerosol Med.
2006;
19
364-371
,
MissingFormLabel
- 7
Horvath G, Wanner A.
Inhaled corticosteroids:
effects on the airway vasculature in bronchial asthma.
Eur
Respir J.
2006;
27
172-187
MissingFormLabel
- 8
Horvath G, Wanner A.
Molecular targets for
steroids in airway vascular smooth muscle.
Arch Physiol
Biochem.
2003;
111
341-344
MissingFormLabel
- 9
Howarth P H.
Why particle size should affect clinical response to inhaled
therapy.
J Aerosol Med.
2001;
14
(Suppl 1)
S27-34
MissingFormLabel
- 10
Int-Veen J C, Beekman A J, Bel E H, Sterk P J.
Recurrent exacerbations in severe asthma are associated with
enhanced airway closure during stable episodes.
Am J Respir
Crit Care Med.
2000;
161
1902-1906
MissingFormLabel
- 11
Irvin C G, Bates JH T.
Physiologic
dysfunction of the asthmatic lung. What’s going on down
there, anyway?.
Proc Am Thorac Soc.
2009;
6
306-311
MissingFormLabel
- 12
Kaminsky D A, Bates JH T, Irvin C G.
Effects of cool, dry air stimulation on
peripheral lung mechanics in asthma.
Am J Respir Care
Med.
2000;
162
179-186
MissingFormLabel
- 13
Kaminsky D A, Irvin C G, Lundblad L K. et al .
Oscillation mechanics
of the human lung periphery in asthma.
J Appl Physiol.
2004;
97
1849-1858
MissingFormLabel
- 14
Kaminsky D A, Irvin C G, Lundblad L K. et al .
Heterogeneity
of bronchoconstriction does not distinguish mild asthmatic subjects
from healthy controls when supine.
J Appl Physiol.
2008;
104
10-19
MissingFormLabel
- 15
Kraft M, Djukanovic R, Wilson S, Holgate S T, Martin R J.
Alveolar tissue inflammation in asthma.
Am J Respir Crit Care Med.
1996;
154
1505-1510
MissingFormLabel
- 16
Lahzami S, King G G.
Targeting small
airways in asthma: the new challenge of inhaled corticosteroid treatment.
Eur Respir J.
2008;
31
1145-1147
MissingFormLabel
- 17
Magnan A, Dubus J C, Voshaar T. et al .
Effect of incorrect use of dry powder inhalers
on asthma management.
Respir Med.
2008;
102
593-604
,
MissingFormLabel
- 18
Tgavalekos N T, Musch G, Harris R S. et al .
Relationship between airway narrowing,
patchy ventilation and lung mechanics in asthmatics.
Eur Respir
J.
2007;
29
1174-1181
MissingFormLabel
- 19
van Veen I H, Sterk P J, Schot R, Gauw S A, Rabe K F, Bel E H.
Alveolar nitric oxide versus measures of peripheral airway dysfunction
in severe asthma.
Eur Respir J.
2006;
27
951-956
MissingFormLabel
- 20
Voshaar Th, App E M, Berdel D. et al .
Empfehlungen für die Auswahl von
Inhalationssystemen zur Medikamentenverabreichung. Arbeitsgruppe
Aerosolmedizin der Deutschen Gesellschaft für Pneumologie.
Pneumologie.
2001;
55
579-586
MissingFormLabel
- 21
Yamaguchi M, Niimi A, Ueda T. et
al .
Effect of inhaled corticosteroids on small airways
in asthma: Investigation using impulse oscillometry.
Pulmonary,
Pharmacology and Therapeutics.
2009;
22
326-332
MissingFormLabel
- 22
Zeidler M R, Kleerup E C, Goldin J G. et al .
Montelukast improves
regional air-trapping due to small airways obstruction in asthma.
Eur Respir J.
2006;
27
307-315
MissingFormLabel
- 23
Zhou J, Liu D -F, Liu C. et al .
Glucocorticoids inhibit degranulation of
mast cells in allergic asthma via nongenomic mechanism.
Allergy.
2008;
63
1177-1185
MissingFormLabel
Dr. Thomas Voshaar
Krankenhaus Bethanien Moers, Medizinische Klinik
III
Bethanienstrasse 21
47441 Moers
Phone: 02841/200 24 10
Email: th.voshaar@bethanienmoers.de